comparemela.com

Latest Breaking News On - Johne kao - Page 6 : comparemela.com

Alignment Healthcare, Inc (NASDAQ:ALHC) Receives $15 64 Average PT from Brokerages

Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Rating) has been given an average recommendation of “Moderate Buy” by the thirteen research firms that are presently covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average twelve-month price objective […]

225,150 Shares in Alignment Healthcare, Inc (NASDAQ:ALHC) Purchased by Assenagon Asset Management S A

Assenagon Asset Management S.A. purchased a new position in Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Rating) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 225,150 shares of the company’s stock, valued at approximately $2,666,000. Several other institutional investors have also modified […]

Alignment Healthcare (ALHC) Scheduled to Post Earnings on Thursday

Alignment Healthcare (NASDAQ:ALHC – Get Rating) is scheduled to post its quarterly earnings results after the market closes on Thursday, August 4th. Analysts expect Alignment Healthcare to post earnings of ($0.26) per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link. Alignment Healthcare (NASDAQ:ALHC […]

Alignment Healthcare (NASDAQ:ALHC) Shares Gap Up to $13 55

Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Rating) gapped up before the market opened on Friday . The stock had previously closed at $13.55, but opened at $14.08. Alignment Healthcare shares last traded at $13.63, with a volume of 2,755 shares. Analyst Ratings Changes A number of analysts have recently issued reports on the stock. William […]

Alignment Healthcare, Inc (NASDAQ:ALHC) Given Consensus Recommendation of Buy by Analysts

Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Rating) has been given a consensus recommendation of “Buy” by the ten ratings firms that are presently covering the stock, MarketBeat reports. Ten analysts have rated the stock with a buy recommendation. The average 12 month price target among brokerages that have updated their coverage on the stock in […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.